No need to change guidelines for diabetic retinopathy and renin-angiotensin system inhibitors

Lancet Diabetes Endocrinol. 2015 Apr;3(4):231-2. doi: 10.1016/S2213-8587(15)70006-9. Epub 2015 Feb 6.
No abstract available

Publication types

  • Comment

MeSH terms

  • Angiotensin Receptor Antagonists / therapeutic use*
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
  • Antihypertensive Agents / therapeutic use*
  • Diabetic Retinopathy / drug therapy*
  • Humans

Substances

  • Angiotensin Receptor Antagonists
  • Angiotensin-Converting Enzyme Inhibitors
  • Antihypertensive Agents